Hyperparathyroidism historical perspective
Hyperparathyroidism Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hyperparathyroidism historical perspective On the Web |
American Roentgen Ray Society Images of Hyperparathyroidism historical perspective |
Risk calculators and risk factors for Hyperparathyroidism historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
Historical Perspective
Discovery
- In 1852, Sir Richard Owen, Hunterian Professor and Conservator of the Museum in the Royal College of Surgeons of England, described parathyroids in rhinoceros.[1]
- In 1880, Ivar Sandström, a Swedish anatomist, described parathyroids in human following 50 autopsies. He found tow parathyroid glands bilaterally in 43 out of 50 autopsies.[2]
- In 1909, William George MacCallum and Carl Voegtlin, demonstrated associatioin between parathyroid gland calcium, and tetany.[3]
- In 1924, James Bertram Collip, a Canadian biochemist, discovered and extracted parathormone.[4]
- In 1932, L. I. Pugsley AND Hans Selye described the histological changes in the bone responsible for action of parathyroid hormone and on calcium metabolism in rat experiments. [5]
- In 1948, Nigel Ashworth Barnicot, an English anthropologist described the association between parathyroid hormone and bone resorption.[6]
- In the same year, Iftakhar Jahan and Robert F. Pitts described effect of parathyroid hormone in decreasing calcium and magnesium excretion.[7]
- In 1959, Howard Rasmussen and Lyman C. Craig at the Rockefeller Institute for Medical Research purified parathyroid hormone.[8] They also isolated the active polypeptide (parathormone B) from bovine parathyroid gland and gave its tentative formula in 1961.[9]
Landmark Events in the Development of Treatment Strategies
- In 1925, James Bertram Collip along with Douglous B Leitch treated tetany with the help of parathyroid hormone extract. They names the extract as Parathyrin.[10]
- In 1925, Felix Mandl, a viennese surgeon performed first parathyroidectomy to treat a patient suffering from suffering from osteitis fibrosa cystica.[11]
References
- ↑ Modarai B, Sawyer A, Ellis H (2004). "The glands of Owen". J R Soc Med. 97 (10): 494–5. doi:10.1258/jrsm.97.10.494. PMC 1079622. PMID 15459265.
- ↑ Johansson H (2015). "The Uppsala anatomist Ivar Sandström and the parathyroid gland". Ups. J. Med. Sci. 120 (2): 72–7. doi:10.3109/03009734.2015.1027426. PMC 4463479. PMID 25913489.
- ↑ Maccallum WG, Voegtlin C (1909). "ON THE RELATION OF TETANY TO THE PARATHYROID GLANDS AND TO CALCIUM METABOLISM". J. Exp. Med. 11 (1): 118–51. PMC 2124703. PMID 19867238.
- ↑ Collip, J. B. (1925). "THE EXTRACTION OF A PARATHYROID HORMONE WHICH WILL PREVENT OR CONTROL PARATHYROID TETANY AND WHICH REGULATES THE LEVEL OF BLOOD CALCIUM". Journal of Biological Chemistry. 63 (2): 395–438.
- ↑ PUGSLEY, L. I.; SELYE, HANS (July 28, 1933). "THE HISTOLOGICAL CHANGES IN THE BONE RESPONSIBLE FOR THE ACTION OF PARATHYROID HORMONE ON THE CALCIUM METABOLISM OF THE RAT". The Journal of Physiology. 79 (1): 113–117.
- ↑ BARNICOT NA (1948). "The local action of the parathyroid and other tissues on bone in intracerebral grafts". J. Anat. 82 (Pt. 4): 233–48. PMID 18113751.
- ↑ JAHAN I, PITTS RF (1948). "Effect of parathyroid on renal tubular reabsorption of phosphate and calcium". Am. J. Physiol. 155 (1): 42–9. PMID 18102666.
- ↑ Rasmussen, Howard; Craig, Lyman C. (1959). "PURIFICATION OF PARATHYROID HORMONE BY USE OF COUNTERCURRENT DISTRIBUTION". Journal of the American Chemical Society. 81 (18): 5003–5003. doi:10.1021/ja01527a066. ISSN 0002-7863.
- ↑ Rasmussen, Howard; Craig, Lyman C. (1961). "Isolation of a Parathyroid Polypeptide from Acetic Acid Extracts of Bovine Parathyroid Glands". {Journal of Biological Chemistry. 236 (4): 1083–1086.
- ↑ Collip JB, Leitch DB (1925). "A Case of Tetany treated with Parathyrin". Can Med Assoc J. 15 (1): 59–60. PMC 1707993. PMID 20315252.
- ↑ Thompson, Scott M.; Thompson, Geoffrey B. (April 8, 2015). Felix Mandl. Surgical Endocrinopathies. p. 153-156. ISBN 978-3-319-13661-5.